• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jaguar Health, Inc. - Common Stock (NQ:JAGX)

    2.120 +0.070 (+3.41%)
    Streaming Delayed Price Updated: 3:13 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 64,337
    Open 2.040
    Bid (Size) 2.100 (2)
    Ask (Size) 2.140 (5)
    Prev. Close 2.050
    Today's Range 2.035 - 2.140
    52wk Range 1.570 - 35.25
    Shares Outstanding 171,350,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
    Via ACCESS Newswire
    Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
    Via ACCESS Newswire

    Performance

    YTD
    -92.2%
    -92.2%
    1 Month
    +20.5%
    +20.5%
    3 Month
    -21.8%
    -21.8%
    6 Month
    -60.6%
    -60.6%
    1 Year
    -92.3%
    -92.3%

    More News

    Read More
    Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
    Via ACCESS Newswire
    Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts
    Via ACCESS Newswire
    Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs
    Via ACCESS Newswire
    Earnings Scheduled For August 14, 2025
    Via Benzinga
    Earnings Preview For Jaguar Health
    Via Benzinga
    Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
    Via ACCESS Newswire
    Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
    Via ACCESS Newswire
    Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
    Via ACCESS Newswire
    Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS
    Via ACCESS Newswire
    Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
    Via ACCESS Newswire
    Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
    Via Stocktwits
    Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
    Via ACCESS Newswire
    Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
    Via ACCESS Newswire
    Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026
    Via ACCESS Newswire
    Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer
    Via ACCESS Newswire
    Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
    Via ACCESS Newswire
    First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
    Via ACCESS Newswire
    REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series
    Via ACCESS Newswire
    Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Jaguar Health, Inc. - Common Stock publicly traded?
    Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
    What exchange does Jaguar Health, Inc. - Common Stock trade on?
    Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
    The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
    What is the current price of Jaguar Health, Inc. - Common Stock?
    The current price of Jaguar Health, Inc. - Common Stock is 2.120
    When was Jaguar Health, Inc. - Common Stock last traded?
    The last trade of Jaguar Health, Inc. - Common Stock was at 09/26/25 03:13 PM ET
    What is the market capitalization of Jaguar Health, Inc. - Common Stock?
    The market capitalization of Jaguar Health, Inc. - Common Stock is 363.26M
    How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
    Jaguar Health, Inc. - Common Stock has 363M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.